The role of multimodality imaging in takotsubo cardiomyopathy

Osamu Manabe; Masanao Naya; Noriko Oyama-Manabe; Kazuhiro Koyanagawa; Nagara Tamaki

doi:10.1007/s12350-018-1312-x

The role of multimodality imaging in takotsubo cardiomyopathy

J Nucl Cardiol. 2019 Oct;26(5):1602-1616. doi: 10.1007/s12350-018-1312-x. Epub 2018 Jun 1.

Authors

Osamu Manabe¹, Masanao Naya², Noriko Oyama-Manabe³, Kazuhiro Koyanagawa⁴, Nagara Tamaki⁵

Affiliations

¹ Department of Nuclear Medicine, Hokkaido University of Graduate School of Medicine, Kita 15 Nishi 7, Kita-Ku, Sapporo, Hokkaido, 060-8638, Japan.
² Department of Cardiovascular Medicine, Hokkaido University of Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan. naya@med.hokudai.ac.jp.
³ Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Japan.
⁴ Department of Cardiovascular Medicine, Hokkaido University of Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
⁵ Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

PMID: 29858766
DOI: 10.1007/s12350-018-1312-x

Abstract

Takotsubo cardiomyopathy (TC) is a syndrome of transient left ventricular (LV) dysfunction mimicking acute coronary syndrome. Although the mechanisms underlying the occurrence of TC are unknown, several imaging techniques contribute to its diagnosis. Here we review the current knowledge about TC, in particular, the pathophysiology and the role of imaging including nuclear cardiovascular medicine.

Keywords: 123I-BMIPP; 123I-MIBG; 18F-FDG PET; Takotsubo cardiomyopathy; cardiovascular magnetic resonance.

Publication types

Review

MeSH terms

3-Iodobenzylguanidine
Acute Coronary Syndrome / diagnostic imaging*
Cardiology / standards
Cardiovascular Diseases
Echocardiography
Fluorodeoxyglucose F18
Heart Ventricles / diagnostic imaging
Humans
Magnetic Resonance Spectroscopy
Multimodal Imaging*
Nuclear Medicine
Positron-Emission Tomography
Radionuclide Imaging
Radiopharmaceuticals
Takotsubo Cardiomyopathy / diagnostic imaging*
Ventricular Dysfunction, Left / diagnostic imaging*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18
3-Iodobenzylguanidine